Effect of a Single Dose of Cranberry Beverage on Inflammation and Oxidative Stress

NCT ID: NCT01780922

Last Updated: 2014-07-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-07-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the effects of a single dose of cranberry beverage in healthy adults on the kinetic uptake of polyphenol compounds and polyphenol metabolites, and antioxidative and anti-inflammatory activity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be randomized based on age, sex and BMI, and will consume a low-polyphenol diet 2 days prior to the intervention. On the day of the study, baseline blood and urine samples will be collected after an overnight fast. Participants will consume the assigned beverage within 15 minutes and blood collected at 2, 4, 8, and 24 h (10 mL/blood draw; total blood volume per period = 50 mL). Urine will be collected for polyphenol analysis during the following periods: 0-3, 3-6, 6-9, 9-12, 12-24 hours. After a one-week washout period, participants will receive their second and then the third beverage in a cross-over design; blood and urine sampling will be repeated at each of the 3 intervention periods.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low Calorie Cranberry Juice Cocktail

Beverage containing cranberry: one dose of 15.2 ounces consumed within 15 minutes

Group Type ACTIVE_COMPARATOR

Low Calorie Cranberry Juice Cocktail

Intervention Type OTHER

Beverage containing cranberry at a dose of 15.2 ounces consumed within 15 minutes

Cranberry Extract Beverage

Beverage containing cranberry: one dose of 15.2 ounces consumed within 15 minutes

Group Type ACTIVE_COMPARATOR

Cranberry Extract Beverage

Intervention Type OTHER

Beverage containing cranberry at a dose of 15.2 ounces consumed within 15 minutes

Non-Cranberry Beverage

Beverage absent cranberry: one dose of 15.2 ounces consumed within 15 minutes

Group Type PLACEBO_COMPARATOR

Non-Cranberry Beverage

Intervention Type OTHER

Beverage absent cranberry at a dose of 15.2 ounces consumed within 15 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low Calorie Cranberry Juice Cocktail

Beverage containing cranberry at a dose of 15.2 ounces consumed within 15 minutes

Intervention Type OTHER

Cranberry Extract Beverage

Beverage containing cranberry at a dose of 15.2 ounces consumed within 15 minutes

Intervention Type OTHER

Non-Cranberry Beverage

Beverage absent cranberry at a dose of 15.2 ounces consumed within 15 minutes

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men \& women; aged 18-35 years
* BMI: 19-25 kg/m2

Exclusion Criteria

* Any significant chronic disease, hypertension, ulcers, dyspepsia, lactose intolerance, allergy, psychotic illness
* Had major gastrointestinal surgery or on prescription or surgical treatment
* Any condition that may interfere with the digestion, absorption, metabolism or excretion of nutrients
* Regularly smoked in the previous 6 months
* On medication or ingested a prescribed drug at any time within the 14 days preceding study enrolment (excluding hormonal contraceptives and hormone replacement therapy) or over-the-counter preparation within 7 days preceding enrolment
* Risk factors for AIDS or known HIV positive status
* Pregnant or lactating
* High intake of chocolate or similar high polyphenol foods
* Regular intake of vitamin and polyphenol supplements
* Drug and alcohol misuse
* Currently participating or had participated in another clinical study during the previous 3 weeks
* Donated blood in the previous 3 weeks
* Exercise more than 3 times/week for longer than 45 min each time
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ocean Spray Cranberries, Inc.

INDUSTRY

Sponsor Role collaborator

Washington State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boon P Chew, PhD

Role: PRINCIPAL_INVESTIGATOR

Washington State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

WSU Bioactives Research Lab

Pullman, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

11369

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hood to Coast Injury Study
NCT00733395 COMPLETED PHASE4